Marshall Wace, LLP Global Cord Blood Corp Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.05 - $3.0 $43,086 - $63,054	-21,018 Reduced 63.02%	12,332 $29,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $3.98 $37,162 - $67,230	16,892 Added 102.64%	33,350 $98,000
Q1 2022 May 16, 2022	BUY	$3.74 - $4.55 $61,552 - $74,883	16,458 New	16,458 $63,000
Q3 2020 Nov 16, 2020	SELL	$2.99 - $3.89 $107,675 - $140,086	-36,012 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.56 - $3.37 $6,812 - $8,967	2,661 Added 7.98%	36,012 $112,000
Q1 2020 May 15, 2020	SELL	$2.98 - $5.22 $17,135 - $30,015	-5,750 Reduced 14.71%	33,351 $106,000
Q4 2019 Feb 14, 2020	BUY	$4.37 - $5.67 $15,697 - $20,366	3,592 Added 10.12%	39,101 $196,000
Q3 2019 Nov 14, 2019	BUY	$4.2 - $5.87 $149,137 - $208,437	35,509 New	35,509 $172,000

44.8K

Ticker CO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 133,915,000
Description
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matchin...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.